Difference between revisions of "Polymorphous adenocarcinoma"
Jump to navigation
Jump to search
(+cat.) |
|||
(26 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{{ Infobox diagnosis | |||
| Name = {{PAGENAME}} | |||
| Image = Polymorphous_low-grade_adenocarcinoma_high_mag.jpg | |||
| Width = | |||
| Caption = Polymorphous adenocarcinoma. [[H&E stain]]. | |||
| Synonyms = polymorphmous low-grade adenocarcinoma (obsolete term) | |||
| Micro = low-grade cytology - nuclei ovoid & small, small nucleoli, powdery chromatin ([[papillary thyroid carcinoma]]-like appearance); eosinophilic cytoplasm; variable architecture - often small nests, classically has whorling ("eye-of-storm") pattern and single file pattern | |||
| Subtypes = | |||
| LMDDx = [[adenoid cystic carcinoma]], [[pleomorphic adenoma]], [[cribriform adenocarcinoma of the minor salivary gland]] | |||
| Stains = | |||
| IHC = S-100 +ve, CK7 +ve, p40 -ve, p63 +ve, vimentin +ve | |||
| EM = | |||
| Molecular = | |||
| IF = | |||
| Gross = | |||
| Grossing = | |||
| Site = [[oral cavity]], [[salivary gland]] | |||
| Assdx = | |||
| Syndromes = | |||
| Clinicalhx = | |||
| Signs = | |||
| Symptoms = | |||
| Prevalence = uncommon (varies by study) | |||
| Bloodwork = | |||
| Rads = | |||
| Endoscopy = | |||
| Prognosis = good | |||
| Other = | |||
| ClinDDx = | |||
}} | |||
'''Polymorphous adenocarcinoma''', abbreviated '''PAC''', is a rare malignant [[salivary gland]] tumour. | |||
It was previously known as '''polymorphous low-grade adenocarcinoma''', abbreviated '''PLGA'''.<ref name=pmid29761209>{{cite journal |authors=Vander Poorten V, Triantafyllou A, Skálová A, Stenman G, Bishop JA, Hauben E, Hunt JL, Hellquist H, Feys S, De Bree R, Mäkitie AA, Quer M, Strojan P, Guntinas-Lichius O, Rinaldo A, Ferlito A |title=Polymorphous adenocarcinoma of the salivary glands: reappraisal and update |journal=Eur Arch Otorhinolaryngol |volume=275 |issue=7 |pages=1681–1695 |date=July 2018 |pmid=29761209 |doi=10.1007/s00405-018-4985-5 |url=}}</ref> | |||
==General== | |||
*Female:male ~= 2:1. | |||
*Older people ~50-70 years old. | |||
*Large variably in the prevalence reported - suggests a lacking of reproducibility in the [[diagnosis]].<ref name=pmid23320410/> | |||
*Slow growing - metastases rare - prognosis good.<ref name=pmid18327037>{{Cite journal | last1 = Paleri | first1 = V. | last2 = Robinson | first2 = M. | last3 = Bradley | first3 = P. | title = Polymorphous low-grade adenocarcinoma of the head and neck. | journal = Curr Opin Otolaryngol Head Neck Surg | volume = 16 | issue = 2 | pages = 163-9 | month = Apr | year = 2008 | doi = 10.1097/MOO.0b013e3282f70441 | PMID = 18327037 }}</ref><ref name=pmid23618791>{{Cite journal | last1 = Fife | first1 = TA. | last2 = Smith | first2 = B. | last3 = Sullivan | first3 = CA. | last4 = Browne | first4 = JD. | last5 = Waltonen | first5 = JD. | title = Polymorphous low-grade adenocarcinoma: a 17 patient case series. | journal = Am J Otolaryngol | volume = 34 | issue = 5 | pages = 445-8 | month = | year = | doi = 10.1016/j.amjoto.2013.03.012 | PMID = 23618791 }}</ref> | |||
==Gross== | |||
*Tumour of the minor [[salivary gland]]s.<ref name=pmid24021444>{{Cite journal | last1 = Andreu-Barasoain | first1 = M. | last2 = Vicente-Martín | first2 = FJ. | last3 = Gómez de la Fuente | first3 = E. | last4 = Salamanca-Santamaría | first4 = J. | last5 = Pampín-Franco | first5 = A. | last6 = López-Estebaranz | first6 = JL. | title = Polymorphous low-grade adenocarcinoma in the upper lip: a well-described but infrequently recognized tumor. | journal = Dermatol Online J | volume = 19 | issue = 8 | pages = 19265 | month = | year = 2013 | doi = | PMID = 24021444 }}</ref> | |||
*Almost exclusively in the [[oral cavity]] - usually palate.<ref name=pmid18327037/> | |||
==Microscopic== | |||
Features:<ref name=Ref_WMSP74>{{Ref WMSP|74}} <!-- Mike S. --></ref> | |||
*Architecture: often small nests, may be targetoid. | |||
**Classically has whorling with '''eye-of-storm''' & '''single file'''. | |||
*Cytologically monotonous (uniform) with variable architecture - '''key feature'''. | |||
**Nucleus: ovoid & small, small nucleoli, powdery chromatin. | |||
***'''[[Papillary thyroid carcinoma]]-like appearance'''. | |||
**Cytoplasm: eosinophilic. | |||
*Indistinct cell borders. | |||
Note: | |||
*''Pretty much always'' a low-grade tumour. | |||
DDx: | |||
*[[Adenoid cystic carcinoma]]. | |||
*[[Pleomorphic adenoma]]. | |||
*[[Cribriform adenocarcinoma of the minor salivary gland]] - if one considers it a separate diagnosis. | |||
**The ''World Health Organization'' lumps ''[[cribriform adenocarcinoma of the minor salivary gland]]'' with ''polymorphous adenocarcinoma''.<ref name=pmid29761209>{{cite journal |authors=Vander Poorten V, Triantafyllou A, Skálová A, Stenman G, Bishop JA, Hauben E, Hunt JL, Hellquist H, Feys S, De Bree R, Mäkitie AA, Quer M, Strojan P, Guntinas-Lichius O, Rinaldo A, Ferlito A |title=Polymorphous adenocarcinoma of the salivary glands: reappraisal and update |journal=Eur Arch Otorhinolaryngol |volume=275 |issue=7 |pages=1681–1695 |date=July 2018 |pmid=29761209 |doi=10.1007/s00405-018-4985-5 |url=}}</ref> | |||
===Images=== | |||
<gallery> | |||
Image:Polymorphous_low-grade_adenocarcinoma_-_very_low_mag.jpg | PLGA - very low mag. (WC/Nephron) | |||
Image:Polymorphous_low-grade_adenocarcinoma_high_mag.jpg | PLGA - high mag. (WC/Nephron) | |||
</gallery> | |||
==IHC== | |||
Features:<ref name=pmid23320410>{{Cite journal | last1 = de Araujo | first1 = VC. | last2 = Passador-Santos | first2 = F. | last3 = Turssi | first3 = C. | last4 = Soares | first4 = AB. | last5 = de Araujo | first5 = NS. | title = Polymorphous low-grade adenocarcinoma: an analysis of epidemiological studies and hints for pathologists. | journal = Diagn Pathol | volume = 8 | issue = | pages = 6 | month = | year = 2013 | doi = 10.1186/1746-1596-8-6 | PMID = 23320410 }}</ref> | |||
*S-100 +ve. | |||
*CK7 +ve. | |||
*Vimentin +ve. | |||
*p63 +ve (22 of 23 cases<ref name=pmid31653135/>). | |||
*p40 -ve (22 of 23 cases<ref name=pmid31653135>{{cite journal |authors=Atiq A, Mushtaq S, Hassan U, Loya A, Hussain M, Akhter N |title=Utility of p63 and p40 in Distinguishing Polymorphous Adenocarcinoma and Adenoid Cystic Carcinoma |journal=Asian Pac J Cancer Prev |volume=20 |issue=10 |pages=2917–2921 |date=October 2019 |pmid=31653135 |pmc=6982655 |doi=10.31557/APJCP.2019.20.10.2917 |url=}}</ref>). | |||
**Useful to differentiate from [[adenoid cystic carcinoma]] (AdCC); AdCC is usually p63 +ve/p40 +ve (36 of 47 cases) or p63 -ve/p40 -ve (10 of 47 cases). | |||
***p63 +ve/p40 +ve is seen in pleomorphic adenoma and mucoepidermoid carcinoma (in addition to adenoid cystic carcinoma).<ref name=pmid34518135>{{cite journal |authors=Sivakumar N, Narwal A, Pandiar D, Devi A, Anand R, Bansal D, Kamboj M |title=Diagnostic utility of p63/p40 in the histologic differentiation of salivary gland tumors: A systematic review |journal=Oral Surg Oral Med Oral Pathol Oral Radiol |volume=133 |issue=2 |pages=189–198 |date=February 2022 |pmid=34518135 |doi=10.1016/j.oooo.2021.07.010 |url=}}</ref> | |||
Others: | |||
*GFAP +ve/-ve. | |||
**One study suggests GFAP cleanly separates the PLGA (-ve) from [[pleomorphic adenoma]] (+ve).<ref name=pmid11174597>{{Cite journal | last1 = Curran | first1 = AE. | last2 = White | first2 = DK. | last3 = Damm | first3 = DD. | last4 = Murrah | first4 = VA. | title = Polymorphous low-grade adenocarcinoma versus pleomorphic adenoma of minor salivary glands: resolution of a diagnostic dilemma by immunohistochemical analysis with glial fibrillary acidic protein. | journal = Oral Surg Oral Med Oral Pathol Oral Radiol Endod | volume = 91 | issue = 2 | pages = 194-9 | month = Feb | year = 2001 | doi = 10.1067/moe.2001.111306 | PMID = 11174597 }}</ref> | |||
*BCL2 +ve/-ve. | |||
*Generally negative for myoepithelial markers (calponin, actin) - '''useful if negative'''. | |||
==See also== | |||
*[[Salivary glands]]. | |||
==References== | |||
{{Reflist|2}} | |||
[[Category:Diagnosis]] | [[Category:Diagnosis]] | ||
[[Category:Salivary gland]] |
Latest revision as of 20:41, 2 June 2024
Polymorphous adenocarcinoma | |
---|---|
Diagnosis in short | |
Polymorphous adenocarcinoma. H&E stain. | |
| |
Synonyms | polymorphmous low-grade adenocarcinoma (obsolete term) |
| |
LM | low-grade cytology - nuclei ovoid & small, small nucleoli, powdery chromatin (papillary thyroid carcinoma-like appearance); eosinophilic cytoplasm; variable architecture - often small nests, classically has whorling ("eye-of-storm") pattern and single file pattern |
LM DDx | adenoid cystic carcinoma, pleomorphic adenoma, cribriform adenocarcinoma of the minor salivary gland |
IHC | S-100 +ve, CK7 +ve, p40 -ve, p63 +ve, vimentin +ve |
Site | oral cavity, salivary gland |
| |
Prevalence | uncommon (varies by study) |
Prognosis | good |
Polymorphous adenocarcinoma, abbreviated PAC, is a rare malignant salivary gland tumour.
It was previously known as polymorphous low-grade adenocarcinoma, abbreviated PLGA.[1]
General
- Female:male ~= 2:1.
- Older people ~50-70 years old.
- Large variably in the prevalence reported - suggests a lacking of reproducibility in the diagnosis.[2]
- Slow growing - metastases rare - prognosis good.[3][4]
Gross
- Tumour of the minor salivary glands.[5]
- Almost exclusively in the oral cavity - usually palate.[3]
Microscopic
Features:[6]
- Architecture: often small nests, may be targetoid.
- Classically has whorling with eye-of-storm & single file.
- Cytologically monotonous (uniform) with variable architecture - key feature.
- Nucleus: ovoid & small, small nucleoli, powdery chromatin.
- Papillary thyroid carcinoma-like appearance.
- Cytoplasm: eosinophilic.
- Nucleus: ovoid & small, small nucleoli, powdery chromatin.
- Indistinct cell borders.
Note:
- Pretty much always a low-grade tumour.
DDx:
- Adenoid cystic carcinoma.
- Pleomorphic adenoma.
- Cribriform adenocarcinoma of the minor salivary gland - if one considers it a separate diagnosis.
- The World Health Organization lumps cribriform adenocarcinoma of the minor salivary gland with polymorphous adenocarcinoma.[1]
Images
IHC
Features:[2]
- S-100 +ve.
- CK7 +ve.
- Vimentin +ve.
- p63 +ve (22 of 23 cases[7]).
- p40 -ve (22 of 23 cases[7]).
- Useful to differentiate from adenoid cystic carcinoma (AdCC); AdCC is usually p63 +ve/p40 +ve (36 of 47 cases) or p63 -ve/p40 -ve (10 of 47 cases).
- p63 +ve/p40 +ve is seen in pleomorphic adenoma and mucoepidermoid carcinoma (in addition to adenoid cystic carcinoma).[8]
- Useful to differentiate from adenoid cystic carcinoma (AdCC); AdCC is usually p63 +ve/p40 +ve (36 of 47 cases) or p63 -ve/p40 -ve (10 of 47 cases).
Others:
- GFAP +ve/-ve.
- One study suggests GFAP cleanly separates the PLGA (-ve) from pleomorphic adenoma (+ve).[9]
- BCL2 +ve/-ve.
- Generally negative for myoepithelial markers (calponin, actin) - useful if negative.
See also
References
- ↑ 1.0 1.1 Vander Poorten V, Triantafyllou A, Skálová A, Stenman G, Bishop JA, Hauben E, Hunt JL, Hellquist H, Feys S, De Bree R, Mäkitie AA, Quer M, Strojan P, Guntinas-Lichius O, Rinaldo A, Ferlito A (July 2018). "Polymorphous adenocarcinoma of the salivary glands: reappraisal and update". Eur Arch Otorhinolaryngol 275 (7): 1681–1695. doi:10.1007/s00405-018-4985-5. PMID 29761209.
- ↑ 2.0 2.1 de Araujo, VC.; Passador-Santos, F.; Turssi, C.; Soares, AB.; de Araujo, NS. (2013). "Polymorphous low-grade adenocarcinoma: an analysis of epidemiological studies and hints for pathologists.". Diagn Pathol 8: 6. doi:10.1186/1746-1596-8-6. PMID 23320410.
- ↑ 3.0 3.1 Paleri, V.; Robinson, M.; Bradley, P. (Apr 2008). "Polymorphous low-grade adenocarcinoma of the head and neck.". Curr Opin Otolaryngol Head Neck Surg 16 (2): 163-9. doi:10.1097/MOO.0b013e3282f70441. PMID 18327037.
- ↑ Fife, TA.; Smith, B.; Sullivan, CA.; Browne, JD.; Waltonen, JD.. "Polymorphous low-grade adenocarcinoma: a 17 patient case series.". Am J Otolaryngol 34 (5): 445-8. doi:10.1016/j.amjoto.2013.03.012. PMID 23618791.
- ↑ Andreu-Barasoain, M.; Vicente-Martín, FJ.; Gómez de la Fuente, E.; Salamanca-Santamaría, J.; Pampín-Franco, A.; López-Estebaranz, JL. (2013). "Polymorphous low-grade adenocarcinoma in the upper lip: a well-described but infrequently recognized tumor.". Dermatol Online J 19 (8): 19265. PMID 24021444.
- ↑ Humphrey, Peter A; Dehner, Louis P; Pfeifer, John D (2008). The Washington Manual of Surgical Pathology (1st ed.). Lippincott Williams & Wilkins. pp. 74. ISBN 978-0781765275.
- ↑ 7.0 7.1 Atiq A, Mushtaq S, Hassan U, Loya A, Hussain M, Akhter N (October 2019). "Utility of p63 and p40 in Distinguishing Polymorphous Adenocarcinoma and Adenoid Cystic Carcinoma". Asian Pac J Cancer Prev 20 (10): 2917–2921. doi:10.31557/APJCP.2019.20.10.2917. PMC 6982655. PMID 31653135. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982655/.
- ↑ Sivakumar N, Narwal A, Pandiar D, Devi A, Anand R, Bansal D, Kamboj M (February 2022). "Diagnostic utility of p63/p40 in the histologic differentiation of salivary gland tumors: A systematic review". Oral Surg Oral Med Oral Pathol Oral Radiol 133 (2): 189–198. doi:10.1016/j.oooo.2021.07.010. PMID 34518135.
- ↑ Curran, AE.; White, DK.; Damm, DD.; Murrah, VA. (Feb 2001). "Polymorphous low-grade adenocarcinoma versus pleomorphic adenoma of minor salivary glands: resolution of a diagnostic dilemma by immunohistochemical analysis with glial fibrillary acidic protein.". Oral Surg Oral Med Oral Pathol Oral Radiol Endod 91 (2): 194-9. doi:10.1067/moe.2001.111306. PMID 11174597.